GLP-1 RAs do not improve migraines

Дата публикации: 19-06-2026 13:15:00

Patients with migraine who began using GLP-1 receptor agonists for obesity did not experience any significant changes in headache outcomes, according to data presented at the American Headache Society 68th Annual Scientific Meeting.However, initiation of these drugs was associated with less health care utilization and treatment escalation compared with topiramate, Scott Yuan, MD, PhD, director, Jefferson Headache Center, Thomas Jefferson University, and colleagues wrote.“GLP-1 receptor agonists have growing biologic plausibility in migraine, but clinical evidence remains limited,

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	GLP-1s linked to elevated rates of hypotensive events	0	0	13-06-2026
2	Novel oral GLP-1 confers glucose, weight reduction	5	7	23-06-2026
3	Semaglutide may reduce fracture risk in type 2 diabetes	0	5	24-06-2026
4	Foundayo bests Farxiga and Ozempic pill in type 2 diabetes trials	0	8	19-06-2026
5	Stanford researchers say your body already makes this Ozempic alternative	0	7	15-06-2026
6	Ozempic tied to improved quality of life in type 2 diabetes, CKD	0	0	12-06-2026
7	Can coffee help ease migraine symptoms? Neurologist explains whether caffeine is a suitable remedy for headaches	0	0	23-06-2026
8	Мигрень может появиться из-за неочевидных причин	0	0	27-02-2025
9	AIIMS-trained neurologist rates 6 popular migraine hacks: Putting hairclips on eyebrows to drinking coffee	0	0	22-06-2026
10	When Diets Don’t Work: Parents Turn to Wegovy for Elementary School Kids	0	0	22-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6. Источник: www.healio.com.